Skip to Main Content

Paper Details

Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data.
Pharmacogenomics J
25
2020
Author NameAffiliation
Nita A LimdiUniversity of Alabama at Birmingham
Larisa H CavallariDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida
William B HillegassUniversity of Mississippi Medical Center
Amber L BeitelsheesUniversity of Maryland
Julie A JohnsonDepartment of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida
Shawn P GarbettVanderbilt University Medical Center
Josh F PetersonVanderbilt University Medical Center
  • 1 - 7

Datasets

Release 1.2